(+961) 1 421 000 ext mira.hleyhel1@usj.edu.lb
Mira Hleyhel est pharmacienne, titulaire dun doctorat en épidémiologie de l'Université Pierre et Marie Curie, Sorbonne Université. Elle travaille actuellement en tant que consultante scientifique en recherche chez Oracle Life Sciences. Elle est également chargée de cours à l'Institut Supérieur de Santé Publique de l'Université Saint-Joseph à Beyrouth, où elle enseigne l'épidémiologie et la biostatistique aux étudiants de master. Mira possède plus de 10 ans d'expérience dans la conduite de recherches quantitatives primaires dans plusieurs domaines thérapeutiques, en utilisant divers designs et méthodologies de recherche.
Diplôme | Université | Pays | Année |
---|---|---|---|
Doctorat en Santé Publique | Université Paris VI | France | 2014 |
Master Sciences, technologies et santé - Méthose de Recherche et environnement et santé | Université Grenoble Alpes | France | 2012 |
Epidémiologie et biostatistiques
Enseignement universitaire hors USJ | Pays | Etablissement | Date début | Date fin |
---|---|---|---|---|
Enseignante | Liban | University of Balamand | 01/01/2019 | 01/01/2021 |
Enseignante | Liban | Université Libanaise (UL) | 01/01/2014 | 01/01/2022 |
Expérience professionnelle | Organisation | Date début | Date fin |
---|---|---|---|
Consultante en épidémiologie | Oracle life sciences | 01/06/2022 | 15/11/2024 |
Médecine et Santé
RAS
1.Hleyhel M, Popovici O, Leuștean M, Reed S, Sadou A, Furegato M, Bluemel B, Duffell E, Mardh O. Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Romania, 2020 to 2023. Euro Surveill. 2024 Jul29(30):2300663. 2.Hleyhel M, Popovici O, Leuștean M, Reed S, Sadou A, Furegato M, Bluemel B, Duffell E, Mardh O. Prevalence of chronic hepatitis C infection in the general population: results from a national survey, Romania, 2020 to 2023. Euro Surveill. 2024 Jul;29(30):2300663. doi: 10.2807/1560-7917.ES.2024.29.30.2300663. PMID: 39056200; PMCID: PMC11274849. 3.Abboud M, Nacouzi C, Chahine Z, Atallah A, Hleyhel M. Dietary Knowledge Eating Habits among Patients with Type 2 Diabetes in Lebanon. Wade AN, editor. Global Health, Epidemiology and Genomics. 2024 Feb 6;2024:3623555. 4.Hanna P*, Issa A*, Noujeim Z, Hleyhel M†, Saleh N†. Assessment of COVID-19 vaccines acceptance in the Lebanese population: A national cross-sectional study. J Pharm Policy Pract. 2022 Jan 11;15(1):5. 5.Nacouzi C, Tarazi V, Kabalane L, Hosry M, Hleyhel M. Knowledge, Use and Practices of liscensed dietitians related to dietary supplements in Lebanon. Public Health Nutr. 2021 Dec 22; 1-11. 6.Hleyhel M*, Haddad C*, Haidar N, Charbachy M, Saleh N. Determinants of knowledge and prevention measures towards COVID-19 pandemic among Lebanese dentists: a cross sectional survey. BMC Oral Health. 2021 May 6;21(1):241. 7.Lahoud N, Rizk R, Hleyhel M, Baaklini M, Zeidan RK, Ajaka N, Rahme D, Maison P, Saleh N, Trends in the Consumption of Antibiotics in the Lebanese Community Between 2004 and 2016. Int J Clin Pharm. 2021 Jan 7. Epub ahead of print. 8.Youssef L, Hallit S, Sacre H, Salameh P, Cherfan M, Akel M, Hleyhel M. Knowledge, Attitudes and Practices towards People Living with HIV/AIDS in Lebanon. PLoS One. 2021 Mar 25;16(3):e0249025. 9.Grabar S, Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, Pradier C, Salmon D, Simon A, Pourcher V, Spano JP, Poizot-Martin I, Costagliola D. Invasive cervical cancer in HIV-infected women: risk and survival relative to those of the general population in France. Results from the French Hospital Database on HIV (FHDH)–Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) CO4 cohort study. HIV med. 2019 Mar; 20(3):222-229. 10.Hleyhel M, Goujon S, Sibiude J, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S; ANRS French Perinatal Cohort study Group. Risk of cancer in children exposed to antiretroviral nucleoside analogues in utero: The french experience. Environ Mol Mutagen. 2017 Dec. [Epub ahead of print]. 11.Hleyhel M, Goujon S, Delteil C, Vasiljevic A, Luzzi S, Stephan JL, Reliquet V, Jannier S, Tubiana R, Dollfus C, Faye A, Mandelbrot L, Clavel J, Warszawski J, Blanche S; on behalf the ANRS French Perinatal Cohort study Group. Risk of cancer in children exposed to didanosine in utero. AIDS. 2016 May; 30(8):1245-56. 12.Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Spano JP, Costagliola D, Grabar S; FHDH-ANRS CO4. Trends in survival after cancer diagnosis among HIV-infected individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 cohort. Int J Cancer. 2015 Nov; 137(10): 2443-53. 13.Hleyhel M, Hleyhel M, Bouvier AM, Belot A, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL, Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Spano JP, Costagliola D, Grabar S; Cancer Risk Group of the French Hospital Database on HIV (FHDH-ANRS CO4). Risk of non-AIDS-defining cancers among HIV-1-infected individuals in France between 1997 and 2009: Results from a French cohort. AIDS. 2014 Sept; 28(14): 2109-2118. 14.Hleyhel M, Belot A, Bouvier AM, Tattevin P, Pacanowski J, Genet P, De Castro N, Berger JL Dupont C, Lavolé A, Pradier C, Salmon D, Simon A, Martinez V, Costagliola D, Grabar S; on behalf of the FHDH-ANRS CO4 cohort. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: Results from the FHDH-ANRS CO4 cohort. Clin Infect Dis. 2013 Dec; 57(11):1638-47.